Login / Signup

Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital.

Gerard GrauEduard Brunet-MasLaura Patricia LlovetPatricia PedregalAlbert VilloriaLuigi MelcarneAnna PuyBelen Garcia-SagueLuis Enrique FrisanchoMaría José Ramírez-LázaroSergio LarioXavier Calvet Calvo
Published in: Journal of clinical medicine (2023)
Thiopurines are a safe drug with few AEs, especially after the first months of treatment. These results suggest that periodic analytic follow-up may not be necessary after the initial period of treatment.
Keyphrases
  • patients with inflammatory bowel disease
  • healthcare
  • combination therapy
  • adverse drug
  • cross sectional
  • drug induced
  • replacement therapy